Search

Neeraj Sharma

Examiner (ID: 5222, Phone: (571)270-5487 , Office: P/2659 )

Most Active Art Unit
2659
Art Unit(s)
2659, 2626
Total Applications
582
Issued Applications
475
Pending Applications
51
Abandoned Applications
71

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 103092 [patent_doc_number] => 07723476 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-25 [patent_title] => 'Anticalins' [patent_app_type] => utility [patent_app_number] => 11/224071 [patent_app_country] => US [patent_app_date] => 2005-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15736 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/723/07723476.pdf [firstpage_image] =>[orig_patent_app_number] => 11224071 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/224071
Anticalins Sep 12, 2005 Issued
Array ( [id] => 5711239 [patent_doc_number] => 20060052584 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Human-derived bradeion proteins, DNA coding for the proteins, and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/224297 [patent_app_country] => US [patent_app_date] => 2005-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8973 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20060052584.pdf [firstpage_image] =>[orig_patent_app_number] => 11224297 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/224297
Human-derived bradeion proteins, DNA coding for the proteins, and uses thereof Sep 12, 2005 Abandoned
Array ( [id] => 9323115 [patent_doc_number] => 08658133 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-25 [patent_title] => 'Methods and compositions relating to alzheimer\'s disease' [patent_app_type] => utility [patent_app_number] => 11/574367 [patent_app_country] => US [patent_app_date] => 2005-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 24218 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 701 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11574367 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/574367
Methods and compositions relating to alzheimer's disease Aug 25, 2005 Issued
Array ( [id] => 4456803 [patent_doc_number] => 07893197 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-22 [patent_title] => 'Relaxin-3 chimeric polypeptides and their preparation and use' [patent_app_type] => utility [patent_app_number] => 11/660883 [patent_app_country] => US [patent_app_date] => 2005-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 24 [patent_no_of_words] => 32001 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/893/07893197.pdf [firstpage_image] =>[orig_patent_app_number] => 11660883 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/660883
Relaxin-3 chimeric polypeptides and their preparation and use Aug 24, 2005 Issued
Array ( [id] => 4813366 [patent_doc_number] => 20080193997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-14 [patent_title] => 'Liquid Preparation of Physiologically Active Peptide' [patent_app_type] => utility [patent_app_number] => 11/660406 [patent_app_country] => US [patent_app_date] => 2005-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17213 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20080193997.pdf [firstpage_image] =>[orig_patent_app_number] => 11660406 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/660406
Liquid Preparation of Physiologically Active Peptide Aug 23, 2005 Abandoned
Array ( [id] => 6931188 [patent_doc_number] => 20050282223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-22 [patent_title] => 'TR3-specific binding agents and methods for their use' [patent_app_type] => utility [patent_app_number] => 11/196919 [patent_app_country] => US [patent_app_date] => 2005-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 19019 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20050282223.pdf [firstpage_image] =>[orig_patent_app_number] => 11196919 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/196919
TR3-specific binding agents and methods for their use Aug 3, 2005 Abandoned
Array ( [id] => 5820412 [patent_doc_number] => 20060024725 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Oncofetal fibronectin as a marker for pregnancy-related indications' [patent_app_type] => utility [patent_app_number] => 11/193857 [patent_app_country] => US [patent_app_date] => 2005-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 165158 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20060024725.pdf [firstpage_image] =>[orig_patent_app_number] => 11193857 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/193857
Oncofetal fibronectin as a marker for pregnancy-related indications Jul 28, 2005 Abandoned
Array ( [id] => 5710959 [patent_doc_number] => 20060052304 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Method for remodeling bone and related sutures' [patent_app_type] => utility [patent_app_number] => 11/191824 [patent_app_country] => US [patent_app_date] => 2005-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9729 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20060052304.pdf [firstpage_image] =>[orig_patent_app_number] => 11191824 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/191824
Method for remodeling bone and related sutures Jul 26, 2005 Abandoned
Array ( [id] => 602281 [patent_doc_number] => 07432044 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-07 [patent_title] => 'Methods and compositions for modulating hepatocyte growth factor activation' [patent_app_type] => utility [patent_app_number] => 11/189230 [patent_app_country] => US [patent_app_date] => 2005-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 46137 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 191 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/432/07432044.pdf [firstpage_image] =>[orig_patent_app_number] => 11189230 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/189230
Methods and compositions for modulating hepatocyte growth factor activation Jul 24, 2005 Issued
Array ( [id] => 5632227 [patent_doc_number] => 20060148697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Methods for treating and preventing brain cancers' [patent_app_type] => utility [patent_app_number] => 11/180668 [patent_app_country] => US [patent_app_date] => 2005-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 10640 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20060148697.pdf [firstpage_image] =>[orig_patent_app_number] => 11180668 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/180668
Methods for treating and preventing brain cancers Jul 13, 2005 Abandoned
Array ( [id] => 7220063 [patent_doc_number] => 20050260669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Antibodies to iron regulating protein -2 (IRP-2) as a diagnostic for neurodegenerative disease' [patent_app_type] => utility [patent_app_number] => 11/174166 [patent_app_country] => US [patent_app_date] => 2005-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29293 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20050260669.pdf [firstpage_image] =>[orig_patent_app_number] => 11174166 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/174166
Antibodies to iron regulating protein -2 (IRP-2) as a diagnostic for neurodegenerative disease Jun 30, 2005 Abandoned
Array ( [id] => 5694186 [patent_doc_number] => 20060154333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Pan-HER antagonists and methods of use' [patent_app_type] => utility [patent_app_number] => 11/172611 [patent_app_country] => US [patent_app_date] => 2005-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6511 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20060154333.pdf [firstpage_image] =>[orig_patent_app_number] => 11172611 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/172611
Pan-HER antagonists and methods of use Jun 29, 2005 Issued
Array ( [id] => 5794009 [patent_doc_number] => 20060014690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Epidermal growth factor receptor antagonists and methods of use' [patent_app_type] => utility [patent_app_number] => 11/172610 [patent_app_country] => US [patent_app_date] => 2005-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 7949 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014690.pdf [firstpage_image] =>[orig_patent_app_number] => 11172610 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/172610
Epidermal growth factor receptor antagonists and methods of use Jun 29, 2005 Issued
Array ( [id] => 6925393 [patent_doc_number] => 20050238648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-27 [patent_title] => 'Composition and method for trating inflammatory disorders' [patent_app_type] => utility [patent_app_number] => 11/157387 [patent_app_country] => US [patent_app_date] => 2005-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 26226 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20050238648.pdf [firstpage_image] =>[orig_patent_app_number] => 11157387 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/157387
Composition and method for trating inflammatory disorders Jun 19, 2005 Abandoned
Array ( [id] => 4658125 [patent_doc_number] => 20080026987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-31 [patent_title] => 'Use of Liver-Selective Glucokinase Activators' [patent_app_type] => utility [patent_app_number] => 11/629711 [patent_app_country] => US [patent_app_date] => 2005-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8346 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20080026987.pdf [firstpage_image] =>[orig_patent_app_number] => 11629711 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/629711
Use of Liver-Selective Glucokinase Activators Jun 16, 2005 Abandoned
Array ( [id] => 5591403 [patent_doc_number] => 20060040855 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Low efficacy gonadotropin agonists and antagonists' [patent_app_type] => utility [patent_app_number] => 11/152601 [patent_app_country] => US [patent_app_date] => 2005-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 13498 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20060040855.pdf [firstpage_image] =>[orig_patent_app_number] => 11152601 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/152601
Low efficacy gonadotropin agonists and antagonists Jun 13, 2005 Abandoned
Array ( [id] => 4802585 [patent_doc_number] => 20080014172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-17 [patent_title] => 'Use of Il-17 in the Treatment of Fertility-Related Disorders' [patent_app_type] => utility [patent_app_number] => 11/596416 [patent_app_country] => US [patent_app_date] => 2005-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 21688 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20080014172.pdf [firstpage_image] =>[orig_patent_app_number] => 11596416 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/596416
Use of Il-17 in the Treatment of Fertility-Related Disorders May 30, 2005 Abandoned
Array ( [id] => 7018744 [patent_doc_number] => 20050220763 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Method of treating idiopathic pulmonary fibrosis with aerosolized IFN-gamma' [patent_app_type] => utility [patent_app_number] => 11/136966 [patent_app_country] => US [patent_app_date] => 2005-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5630 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20050220763.pdf [firstpage_image] =>[orig_patent_app_number] => 11136966 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/136966
Method of treating idiopathic pulmonary fibrosis with aerosolized IFN-gamma May 24, 2005 Abandoned
Array ( [id] => 5894373 [patent_doc_number] => 20060002912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Methods for preventing post endoscopic retrograde cholangiopancreatography pancreatitis' [patent_app_type] => utility [patent_app_number] => 11/130428 [patent_app_country] => US [patent_app_date] => 2005-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7131 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20060002912.pdf [firstpage_image] =>[orig_patent_app_number] => 11130428 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/130428
Methods for preventing post endoscopic retrograde cholangiopancreatography pancreatitis May 15, 2005 Issued
Array ( [id] => 4698838 [patent_doc_number] => 20080221022 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-11 [patent_title] => 'Prouroguanylin, and Synthetic Analogs or Proteolytic Cleavage Products Derived from It, as Therepeutic and Diagnostic Agents for Diseases Involving Salt and/or Fluid Homeostasis' [patent_app_type] => utility [patent_app_number] => 11/596493 [patent_app_country] => US [patent_app_date] => 2005-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16954 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20080221022.pdf [firstpage_image] =>[orig_patent_app_number] => 11596493 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/596493
Prouroguanylin, and synthetic analogs or proteolytic cleavage products derived from it, as therapeutic and diagnostic agents for diseases involving salt and/or fluid homeostasis May 15, 2005 Issued
Menu